Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Anticancer Research|April 12, 2015
Targeting mTOR and AREG with everolimus, sunitinib and sorafenib in HPV-positive and -negative SCCChristoph Aderhold, Anne Faber, Claudia Umbreit, et al.In Vivo (Athens, Greece)|September 6, 2014
Influence of static magnetic fields combined with human insulin-like growth factor 1 on human satellite cell culturesRichard Birk, J Ulrich Sommer, Dominik Haas, et al.Oncology Letters|December 19, 2013
Interaction of a CD44+ head and neck squamous cell carcinoma cell line with a stromal cell-derived factor-1-expressing supportive niche: An <i>in vitro</i> modelAnne Faber, Christoph Aderhold, Ulrich Reinhart Goessler, et al.Ergonomics|April 18, 2012
Implementation of physical coordination training and cognitive behavioural training interventions at cleaning workplaces--secondary analyses of a randomised controlled trialMarie B Jørgensen, Anne Faber, Tobias Jespersen, et al.Molecular Medicine Reports|April 1, 2014
Evaluation of the effect of static magnetic fields combined with human hepatocyte growth factor on human satellite cell culturesRichard Birk, Ulrich Sommer, Anne Faber, et al.Oncology Reports|June 4, 2014
Imatinib-associated matrix metalloproteinase suppression in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitroClaudia Umbreit, Christoph Aderhold, Anne Faber, et al.Anticancer Research|March 10, 2015
Small molecules alter VEGFR and PTEN expression in HPV-positive and -negative SCC: new hope for targeted-therapyChristoph Aderhold, Anne Faber, Claudia Umbreit, et al.Anticancer Research|July 1, 2015
MMP9, Cyclin D1 and β-Catenin Are Useful Markers of p16-positive Squamous Cell Carcinoma in Therapeutic EGFR Inhibition In VitroClaudia Umbreit, Philipp Erben, Anne Faber, et al.Anticancer Research|December 16, 2014
Incomplete epithelial-mesenchymal transition in p16-positive squamous cell carcinoma cells correlates with β-catenin expressionClaudia Umbreit, Julia Flanjak, Christel Weiss, et al.Oncology Reports|May 28, 2011
CD44 as a stem cell marker in head and neck squamous cell carcinomaAnne Faber, Christine Barth, Karl Hörmann, et al.Pageof 5